IL115029A0 - 2,3-bridged 1,4-dihydropyridines their preparation and use - Google Patents

2,3-bridged 1,4-dihydropyridines their preparation and use

Info

Publication number
IL115029A0
IL115029A0 IL11502995A IL11502995A IL115029A0 IL 115029 A0 IL115029 A0 IL 115029A0 IL 11502995 A IL11502995 A IL 11502995A IL 11502995 A IL11502995 A IL 11502995A IL 115029 A0 IL115029 A0 IL 115029A0
Authority
IL
Israel
Prior art keywords
dihydropyridines
bridged
preparation
Prior art date
Application number
IL11502995A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL115029A0 publication Critical patent/IL115029A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL11502995A 1994-08-25 1995-08-22 2,3-bridged 1,4-dihydropyridines their preparation and use IL115029A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4430092A DE4430092A1 (de) 1994-08-25 1994-08-25 2,3-Cyclisch kondensierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
IL115029A0 true IL115029A0 (en) 1995-12-08

Family

ID=6526497

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11502995A IL115029A0 (en) 1994-08-25 1995-08-22 2,3-bridged 1,4-dihydropyridines their preparation and use

Country Status (15)

Country Link
US (1) US6121284A (zh)
EP (1) EP0705830A1 (zh)
JP (1) JPH0859622A (zh)
KR (1) KR960007594A (zh)
CN (1) CN1127250A (zh)
AU (1) AU3011095A (zh)
CA (1) CA2156672A1 (zh)
CZ (1) CZ217495A3 (zh)
DE (1) DE4430092A1 (zh)
FI (1) FI953956A (zh)
HU (1) HU218209B (zh)
IL (1) IL115029A0 (zh)
NO (1) NO953321L (zh)
PL (1) PL310147A1 (zh)
SK (1) SK104495A3 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
US6593335B1 (en) 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
JP2002528452A (ja) * 1998-10-28 2002-09-03 アボット・ラボラトリーズ ジヒドロピリジン化合物および使用方法
US6538004B2 (en) 2000-03-03 2003-03-25 Abbott Laboratories Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
MXPA02008615A (es) * 2000-03-03 2003-04-14 Abbott Lab Abridores de canales de potasio de dihidropirazolona triciclica y dihidroisoxazolona triciclica.
US20050075359A1 (en) * 2003-03-14 2005-04-07 Rikako Kono Large conductance calcium-activated K channel opener
TW200519091A (en) * 2003-09-10 2005-06-16 Synta Pharmaceuticals Corp Dihydropyridine compounds for treating or preventing metabolic disorders
US8916550B2 (en) * 2005-05-09 2014-12-23 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
TWI401254B (zh) * 2005-05-09 2013-07-11 Hydra Biosciences Inc 用於調節ｔｒｐｖ３功能之化合物
US9233926B2 (en) * 2008-09-17 2016-01-12 Sanford-Burnham Medical Research Institute Compounds for stem cell differentiation
US9012217B2 (en) * 2008-09-17 2015-04-21 Burnham Institute For Medical Research Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
US4021434A (en) * 1972-01-22 1977-05-03 Yamanouchi Pharmaceutical Co., Ltd. Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate
GB1430961A (en) 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3443678A1 (de) * 1984-11-30 1986-06-05 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 4-acyloxy-3-oxo-buttersaeureestern
DE3521761A1 (de) * 1985-06-19 1987-01-02 Bayer Ag Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
DE3629545A1 (de) * 1986-08-30 1988-03-10 Bayer Ag Dihydropyridinverbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester

Also Published As

Publication number Publication date
SK104495A3 (en) 1996-06-05
KR960007594A (ko) 1996-03-22
US6121284A (en) 2000-09-19
HU9502503D0 (en) 1995-10-30
HU218209B (hu) 2000-06-28
FI953956A0 (fi) 1995-08-23
CA2156672A1 (en) 1996-02-26
FI953956A (fi) 1996-02-26
EP0705830A1 (de) 1996-04-10
JPH0859622A (ja) 1996-03-05
CZ217495A3 (en) 1996-03-13
HUT74615A (en) 1997-01-28
AU3011095A (en) 1996-03-07
PL310147A1 (en) 1996-03-04
DE4430092A1 (de) 1996-02-29
NO953321L (no) 1996-02-26
CN1127250A (zh) 1996-07-24
NO953321D0 (no) 1995-08-24

Similar Documents

Publication Publication Date Title
IL116325A0 (en) Substituted 1h-imidazoles their preparation and use
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
EP0710667A3 (de) Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
NZ314419A (en) Substituted 2,4-aryl-3-hydroxyalkyl pyridines; preparation and medicaments
NZ329176A (en) 2,5-dioxo-imidazolidine derivatives and medicaments
HUP9903691A3 (en) Pesticidal karbanilide derivatives, preparation and use thereof
IL120125A0 (en) Substituted oxazolidinones their preparation and their use
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
HU9501086D0 (en) Organoaluminoxy product, preparation and use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
HUP9904032A3 (en) 1,2,4-benzothiadiazine derivatives,their preparation and use
IL115029A0 (en) 2,3-bridged 1,4-dihydropyridines their preparation and use
IL114305A0 (en) 2,4,6-triiodo-5-substituted-amino-isophthalate esters and their use
IL116710A0 (en) Substituted 2-phenylpyridines their preparation and use
IL116712A0 (en) Substituted 2-phenylpyridines their preparation and use
HUP9600730A1 (en) 1,4-tetrazolinone-derivatives and use thereof as herbicides
GB9420616D0 (en) Method, compositions and use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
IL116711A0 (en) Substituted 2-phenylpyridines their preparation and use
IL122686A0 (en) Benzylhydroxylamines their preparation and use
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
EP0442086A3 (en) Graftcopolymers, their preparation and their use
HU9603575D0 (en) Amino-acid-derivatives and their use as pesticide
NZ323282A (en) N,n'-bridged bisindolylmaleimides and their use to prepare n,n'-bridged bisindolylmaleimides